Neurocrine Biosciences, Inc. (NBIX)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$130.06
+1.51%
Mkt Cap $13.07B
Analyst Ratings
Buy
24
Hold
3
Sell
0
Price Target (64 analysts)
$173.67
Range $140.00 – $220.00
Implied Upside
+33.5%
Consensus $173.67 vs current $130.06